As the former Minister of Health and Population in Egypt and the architect of one of the most successful public health campaigns in history, which led to the elimination of hepatitis C from our nation, I now stand as an advisor for the Hepatitis Fund, passionately advocating for the widespread administration of the hepatitis B vaccine, particularly in the early vaccination of newborns.
Hepatitis B is a preventable viral infection that poses a significant health risk to millions, especially to our most vulnerable population: newborns. Advocating for the universal vaccination of infants at birth is not just a public health priority; it is our moral obligation to protect future generations.
The statistics are indeed alarming: approximately 296 million people around the world are living with chronic hepatitis B, with about 1.5 million new infections reported each year. Infants who contract this virus face an overwhelming 95% chance of developing chronic infections, with a tragic 25% of these children likely to fall victim to severe liver disease. The hepatitis B vaccine is a life-saving intervention, offering 98–100% protection for those vaccinated within the first 24 hours of life against this dangerous virus.
By ensuring that every newborn receives the hepatitis B vaccine during these critical early hours, we not only protect them from immediate dangers but also prevent potential lifelong health complications. This vaccination could avert millions of cases of chronic hepatitis, significantly reducing rates of cirrhosis and liver cancer and ultimately saving countless lives.
Establishing a comprehensive hepatitis B vaccination program is not only a cost-effective strategy but also a necessary one that demands global commitment and collaborative action.
As advocates for child health, we must mobilize resources to ensure that every newborn, particularly in high-prevalence areas, has access to this essential vaccine.
Let us unite in championing the hepatitis B vaccine by ensuring that every newborn has equitable access and by educating communities on the critical importance of early vaccination. By doing so, we can create a healthier future for millions of children worldwide, free from the dangers of hepatitis B. Vaccination is not just a choice; it is an essential action that has the power to save lives and establish a stronger foundation for overall health. I encourage everyone to join us in this vital mission—let’s advocate for the hepatitis B vaccine for the newborn now!
Dr. Hala Zaid,
Former Minister of Health and Population of Egypt and Advisor for Strategic Partnership for The Hepatitis Fund
Dr. Hala Zaid is a seasoned healthcare executive with more than 33 years of expertise spanning health system reform, medical education, and strategic leadership. As an Adviser for Strategic Partnerships at The Hepatitis Fund, Dr. Zaid fosters global collaborations to accelerate the elimination of viral hepatitis.
Previously, Dr. Zaid held the position of Egypt’s Minister of Health and Population, where she championed the nation’s landmark hepatitis C elimination campaign and oversaw the rollout of universal health coverage. Her leadership also extended to pharmaceutical innovation, having chaired both VACSERA and ACDIMA, where she played a pivotal role in enhancing Egypt’s vaccine production capabilities.
